METABOLIC DISRUPTION

Pharmaceuticals, namely, agents to treat cancer, autoimmunity, chronic viral infections, and other diseases characterized by abnormal cellular proliferation, and to improve tissue regeneration, wound healing, and transplantation; and kits primarily comprising reagents for medical use in detemining the metabolic pathway used by tumors.

Licensing of intellectual property